Description

Andifen ІS (metamizole sodium monohydrate) tablets №10

Ingredients

Active ingredient: Metamizole sodium monohydrate

Dosage

Dosage: The usual dose for adults is 500-1000 mg taken every 6 hours as needed. Do not exceed 4000 mg in 24 hours.

Indications

Indications: Andifen ІS tablets are indicated for the relief of mild to moderate pain such as headache, toothache, menstrual cramps, and muscle aches.

Contraindications

Contraindications: Do not use Andifen ІS if you have a history of hypersensitivity to metamizole or other pyrazolones.

Directions

Directions: Swallow the tablets whole with a full glass of water. Do not crush or chew the tablets.

Scientific Evidence

Andifen ІS tablets containing metamizole sodium monohydrate have been extensively studied for their analgesic and antipyretic effects. Research has shown that metamizole is effective in relieving pain and reducing fever by inhibiting the production of prostaglandins.

Additional Information

It is important to follow the recommended dosage and not exceed the maximum daily dose to avoid potential side effects. If you have any concerns or experience any adverse reactions, consult a healthcare professional immediately.

Pharmacological Effects

Metamizole sodium monohydrate works by inhibiting the synthesis of prostaglandins, which are substances in the body that cause pain and fever. By blocking the production of these chemicals, Andifen ІS tablets help to alleviate pain and reduce fever effectively.

Clinical Trials and Comparative Effectiveness

Clinical trials have demonstrated the efficacy of metamizole sodium monohydrate in providing rapid and long-lasting pain relief compared to placebo. Additionally, studies have shown that Andifen ІS tablets have comparable effectiveness to other nonsteroidal anti-inflammatory drugs (NSAIDs) in managing pain and fever.

Overall, Andifen ІS tablets containing metamizole sodium monohydrate are a reliable option for the symptomatic relief of various types of pain and fever, backed by scientific evidence and clinical trials.